Body and Mind Provides Corporate Update

• Most Recent News (May 12, 2026): Body and Mind Inc. closed a transaction regarding its equity interest in BaM Body and Mind Dispensary NJ, Inc. The company sold all equity interests to Ascend New Jersey, LLC and a Social Equity Partner.
• Ownership Change: Post-closing structure is 35% owned by Ascend New Jersey, LLC and 65% by the Social Equity Partner.
• Cash Release: $1 million in escrow funds was released to DEP Nevada, Inc. (subsidiary) following waiver of post-closing conditions.
• Historical Context (April 10, 2026): Company completed purchase of two Illinois dispensary interests (NMG IL 4 and NMG IL 1). Cash payments totaled approximately $2.5 million net of debt repayments.
• Earnout Provisions: Both Illinois transactions include earnouts equal to 3.2x EBITDA for months 4–15 post-regulatory approval.

• Cash Flow Impact: The release of $1 million in escrow funds provides immediate liquidity to the subsidiary, DEP Nevada, Inc. For a company trading at $0.03 per share, this cash injection is operationally significant but does not fundamentally alter the balance sheet structure given the lack of market cap data.
• Strategic Shift: The transaction represents a divestiture in New Jersey (selling down to partners) concurrent with acquisition expansion in Illinois. This suggests a strategic pivot or liquidity management rather than pure organic growth.
• Market Expectation: The April 2026 news explicitly stated these deals were "previously announced." The May 12 news describes closing conditions being waived, implying the market was aware of the pending transaction structure. Therefore, this is largely priced in.
• Risk Assessment: Selling equity reduces future profit participation from the NJ asset (from 100% implied to 35%). While cash comes in now, long-term upside from that specific dispensary is capped by the partner's majority stake.
• Rating Justification: Classified as Routine - Positive because it confirms a previously anticipated closing and releases restricted cash without introducing new strategic partnerships or major M&A surprises that would warrant a "Material" re-rating of the company's valuation trajectory.

• Company: Body and Mind Inc. (BAMM).
• Business Model: Cannabis dispensary ownership, management services agreements, and M&A in regulated markets.
• Flagship Projects: Expansion of Illinois footprint (NMG IL 4 and NMG IL 1) and restructuring of New Jersey assets (BaM Body and Mind Dispensary NJ, Inc.).
• Development Status: Active portfolio management involving acquisitions in Illinois and divestitures/partnerships in New Jersey.
• Operational Focus: Shifting capital from NJ equity to IL expansion while maintaining cash flow through escrow releases.